cash flow reconciliationreview2024-12-31
Operating, investing and financing flows differ from the reported change in cash by 13369000, beyond tolerance 5651030.00.
Revenue
$3.55B
Fiscal year ended 2026-06-30Operating income
$579.00M
Fiscal year ended 2026-06-30Free cash flow
$320.25M
Fiscal year ended 2026-06-30DAVITA INC. (DVA) reported revenue of $3.55B and net income of $265.40M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from DAVITA INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Misc Health & Allied Services, NEC.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | $579.00M | $481.89M | $561.07M | $505.77M | $537.84M | $438.94M | $565.36M | $534.88M | $506.40M | $483.84M |
| Net income | $265.40M | $197.53M | $234.22M | $150.33M | $199.34M | $162.92M | $259.33M | $214.69M | $222.68M | $239.65M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 66.09M | shares 68.88M | Unavailable | shares 73.77M | shares 77.36M | shares 81.28M | Unavailable | shares 85.80M | shares 88.95M | shares 90.55M |
| Pretax income | $435.01M | $341.23M | $382.76M | $308.80M | $368.93M | $286.33M | $413.73M | $373.43M | $371.44M | $371.79M |
| Income tax expense | $91.79M | $66.20M | $76.73M | $68.55M | $93.71M | $54.12M | $64.49M | $77.67M | $71.69M | $65.81M |
| Diluted EPS | $4.02 | $2.87 | Unavailable | $2.04 | $2.58 | $2.00 | Unavailable | $2.50 | $2.50 | $2.65 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $423.46M | $421.91M | $472.36M | $414.37M | $412.80M | $374.09M | $414.48M | $393.53M | $367.84M | $362.48M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $668.96M | $644.24M | $676.44M | $705.96M | $708.42M | $438.78M | $794.93M | $1.07B | $416.49M | $345.13M |
| Total assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B |
| Current assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B |
| Total liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B |
| Current liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B |
| Total equity incl. NCI | -$481.98M | -$476.34M | -$373.73M | -$304.23M | -$107.97M | -$6.55M | $395.87M | $586.66M | $850.02M | $1.13B |
| Temporary (mezzanine) equity | $1.56B | $1.52B | $1.53B | $1.64B | $1.66B | $1.67B | $1.70B | $1.63B | $1.57B | $1.50B |
| Inventory | $151.54M | $141.61M | $160.63M | $139.09M | $146.30M | $150.52M | $134.56M | $129.00M | $126.76M | $145.81M |
| Accounts receivable | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B |
| Long-term debt | $10.66B | $10.51B | $10.16B | $10.18B | $10.08B | $9.56B | $9.18B | $9.26B | $8.45B | $9.00B |
| Accounts payable | $715.87M | $691.26M | $696.15M | $655.60M | $594.40M | $596.14M | $547.20M | $488.24M | $493.53M | $489.88M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $490.07M | $320.83M | $540.73M | $841.53M | $324.24M | $180.01M | $547.63M | $810.40M | $798.85M | -$134.84M |
| Capital expenditures | $169.82M | $102.02M | $145.43M | $166.08M | $121.09M | $143.26M | $170.66M | $139.05M | $124.72M | $121.02M |
| Investing cash flow | -$194.25M | -$139.09M | -$163.13M | -$262.52M | -$67.16M | -$162.14M | -$247.97M | -$146.49M | -$161.76M | -$215.21M |
| Financing cash flow | -$270.18M | -$213.34M | -$414.52M | -$582.16M | $4.45M | -$382.54M | -$565.10M | -$7.86M | -$563.30M | $319.32M |
| Net change in cash | $25.46M | -$31.34M | -$37.67M | -$1.54M | $272.39M | -$355.25M | -$278.82M | $655.40M | $72.46M | -$33.85M |
| Stock-based compensation | $26.03M | $28.16M | $38.39M | $38.99M | $32.81M | $29.76M | $27.40M | $26.56M | $24.29M | $24.54M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $181.48M | $196.37M | $274.48M | $240.05M | $283.67M | $510.16M | $365.38M | $407.94M | $361.65M | $250.96M |
| Depreciation & amortization | $167.81M | $177.83M | $186.70M | $177.49M | $174.70M | $176.45M | $174.10M | $187.01M | $175.66M | $187.08M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $320.25M | $218.81M | $395.30M | $675.44M | $203.14M | $36.75M | $376.97M | $671.36M | $674.12M | -$255.85M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | 16.3% | 14.1% | 15.5% | 14.8% | 15.9% | 13.6% | 17.2% | 16.4% | 15.9% | 15.8% |
| FCF margin | 9.0% | 6.4% | 10.9% | 19.7% | 6.0% | 1.1% | 11.4% | 20.6% | 21.2% | -8.3% |
| SBC / revenue | 0.7% | 0.8% | 1.1% | 1.1% | 1.0% | 0.9% | 0.8% | 0.8% | 0.8% | 0.8% |
| Current ratio | 1.47x | 1.42x | 1.29x | 1.36x | 1.39x | 1.25x | 1.26x | 1.37x | 1.16x | 1.43x |
| Revenue YoY growth | 5.2% | 6.0% | 9.9% | 4.8% | 6.1% | 5.0% | 4.7% | 4.6% | 6.2% | 6.9% |
| Net margin | 7.5% | 5.8% | 6.5% | 4.4% | 5.9% | 5.1% | 7.9% | 6.6% | 7.0% | 7.8% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 4.8% | 3.0% | 4.0% | 4.9% | 3.6% | 4.4% | 5.2% | 4.3% | 3.9% | 3.9% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 23.18x | 15.78x | 9.94x | 7.95x |
| Effective tax rate | 21.1% | 19.4% | 20.0% | 22.2% | 25.4% | 18.9% | 15.6% | 20.8% | 19.3% | 17.7% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open DVA in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-04View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-02-11View SEC filing
10-Q · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-12View SEC filing
Reconciliation checks needing review
3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
cash flow reconciliationreview2023-12-31
Operating, investing and financing flows differ from the reported change in cash by 5846000, beyond tolerance 4852050.00.
cash flow reconciliationreview2022-12-31
Operating, investing and financing flows differ from the reported change in cash by 22783000, beyond tolerance 3437220.00.